CytoSorbents Corporation (CTSO)

[Biotech675]

2 of my posts have been removed for being "off topic and spam". Not once have I said anything incorrect or misleading about CTSO or Spectral. All information has been factual and it's about educating people on here about Cytosorbs DIRECT COMPETITION. That is completely ON TOPIC as it has a direct effect on the perceived success of cytosorb. Anybody who doesn't want to see this is just being a very novice investor and a child just seeing or listening to what they want to hear.

5% was not the result of the trial, it was an overall result as there was a too far gone group which skewed those results due to only being able to remove less than 50% of the endotoxin in the blood. With more treatments (exactly what CTSO does by varying the amount of treatments based on the condition you experience better results. THIS IS PERSONALIZED MEDECINE this is what the world is coming to. The fact is that CTSO is doing the exact thing Spectral is by varying dosing based on the patient. Imagine a trial where you could only use 2 treatments on patients which had a varying level of illness, some of which were much sicker than others and you gave them all the same treatment. There will be a skewed portion of those results as well effecting the overall results making it LOOK like a failed trial. the subgroup numbers achieved were statistically and clinically significant, that's what the FDA will look at. The Euphrates Trial was about using EAA to pinpoint where a treatment with a long standing safety record works and where it doesn't. The Taiwanese study will only confirm this as Euphas did.

Also don't forget SOC right now does not include EAA. In the trial EAA was included so nurses could see levels rising and respond more effectively along with the fact this treatment was done at some of the top hospitals in the US where the SOC is arguably better. This directly indicates a skewed sham group mortality rate. Change the sham mortality alone and you have a successful trial nevermind fixing the underdosing of the sicker patients.